Paydirt
Insider filing · ARWR

James C Hamilton sold $450K of Arrowhead Pharmaceuticals (ARWR)

Executed Sep 12 2025, disclosed Sep 16 2025, 4 days later.

Value, as filed
$450K
15,000 sh × $30.00
Executed
Sep 12 2025
the trade date, as filed
Disclosed
Sep 16 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
JH James C Hamilton Chief Medical Officer profile →

James C Hamilton (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $2.4M of ARWR (38,218 sh across 4 lots, as filed), executed Jan 5.

The name
ARWR Arrowhead Pharmaceuticals, Inc. ARWR · Healthcare · 34 filings in 24 months ticker →

Healthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by James C Hamilton in ARWR
ARWRSALE Arrowhead Pharmaceuticals, Inc. $750K
10,000 sh × $75.00
Exec Apr 23
Filed Apr 24 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $642K
10,000 sh × $64.19
Exec Mar 5
Filed Mar 9 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $2.4M
38,218 sh across 4 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $700K
20,000 sh × $35.00
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $375K
15,000 sh × $25.00
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $188K
9,389 sh × $20.00
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $649K
32,729 sh across 2 lots
Exec Jan 6 2025
Filed Jan 7 2025 · 5:30 PM ET